Search results
A Guide for All Medicare Whistleblowers
The National Law Review· 4 hours agoBecoming a whistleblower and notifying federal authorities of Medicare fraud is a big public service and can even lead to a lucrative whistleblower...
Novo Nordisk sales up 26% driven by GLP-1s, misses 11% on Wegovy
Yahoo Finance· 4 hours agoJørgensen defended the pricing, noting that it is down 40% compared to when it launched in 2018, and...
Novo sees Wegovy sales dip on lower price, tight supply
BioPharma Dive via Yahoo Finance· 8 hours agoThe result was a slight sales decline...including Medicaid programs in 15 states and some people...
Drug discount program is exploiting poor patients while corporate giants profit
Minnesota Reformer via Yahoo News· 6 days agoMinnesotans, with their long-valued sense of fairness and decency, would never suggest that Fortune...
What is the Medicare Donut Hole and What Are Your Options?
Penny Hoarder via AOL· 5 days agoMedicare can feel complicated. It’s easy to get overwhelmed when sorting through pages of...
CVS Health Corporation (NYSE:CVS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 hours agoCVS Health Corporation (NYSE:CVS) Q1 2024 Earnings Call Transcript May 1, 2024 CVS Health...
As UnitedHealth grows richer and more powerful, patients get left behind
The Bergen Record via Yahoo Finance· 2 days agoFor instance, it's not uncommon for a PBM like OptumRx to secure enormous discounts from prescription drug companies. Insurers — in this case United Healthcare ...
CVS posts big earnings miss, cuts profit outlook on higher medical costs
CNBC· 1 day agoCVS Health on Wednesday reported first-quarter revenue and adjusted earnings that missed expectations and slashed its full-year profit outlook, citing higher medical costs that are dogging the ...
Elrexfio and cost: Reducing long-term drug costs and more
Medical News Today· 1 day agoElrexfio is a prescription drug used to treat multiple myeloma. Learn how to lower long-term costs,...
Steep Ozempic, Wegovy prices face fresh scrutiny from officials
Axios· 3 days agoWhy it matters: With the drugs now available for heart risks and potentially soon for other...